Viewing data from:

FINASTERIDE

ANDA

FINASTERIDE | A077578 | MYLAN PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain8 active DMFs5 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDFINASTERIDE USP

DMF 157782001

DR REDDYS LABORATORIES LTDFINASTERIDE USP (FORM III)

DMF 160102002

STERLING SPAFINASTERIDE

DMF 184832005

APITORIA PHARMA PRIVATE LTDFINASTERIDE USP

DMF 193082006

HETERO LABS LTDFINASTERIDE

DMF 208932007

MSN LABORATORIES PRIVATE LTDFINASTERIDE USP

DMF 212762008

SUN PHARMACEUTICAL INDUSTRIES LTDFINASTERIDE USP

DMF 213002008

HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO LTDFINASTERIDE

DMF 250562011

GEDEON RICHTER PLCInactiveFINASTERIDE USP

DMF 175752004

CIPLA LTDInactiveFINASTERIDE USP

DMF 176802004

CRYSTAL PHARMA SAUInactiveFINASTERIDE

DMF 185512005

DR REDDYS LABORATORIES LTDInactiveFINASTERIDE (FORM I)

DMF 205212007

YUAN XINYANInactiveFINASTERIDE (API)

DMF 226752009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 18, 2006

No patent or exclusivity listings for this strength.